NASDAQ:RPRX

Royalty Pharma Stock Insider Trading

Healthcare > Biotechnology

Buy RPRX

*Your capital is at risk

$54.97

+0.96 (+1.78%)

At Close: Jun 03, 2026

Royalty Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.66. In total, the insiders bought 1.73M and sold 1.78M RPRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-64.66
● Buy	1.73M shares
● Sell	1.78M shares
29% Buy Activity Moderate Negative Correlation
Sell Signal High Confidence May 26, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -64.66. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 05, 2025 Sell	Class A Ordinary Shares S-Sale	Urist Marshall EVP, Research & Investments	Officer	23 334 Value: $913.6K
Dec 05, 2025 Sell	Class A Ordinary Shares S-Sale	Urist Marshall EVP, Research & Investments	Officer	18 242 Value: $714.2K
Dec 03, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	110 000 Value: $4.38M
Dec 01, 2025 Sell	Class A Ordinary Shares S-Sale	Urist Marshall EVP, Research & Investments	Officer	18 242 Value: $727.9K
Dec 01, 2025 Sell	Class A Ordinary Shares S-Sale	Urist Marshall EVP, Research & Investments	Officer	23 333 Value: $931.6K
Dec 01, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	3 750 Value: $149.5K
Dec 01, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	65 832 Value: $2.62M
Nov 24, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	624 Value: $23.7K
Nov 24, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	55 146 Value: $2.13M
Nov 24, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	10 686 Value: $405.6K
Nov 24, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	3 126 Value: $120.9K
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	25 530 Value: $977.3K
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	47 401 Value: $1.81M
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	4 628 Value: $180.5K
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	2 770 Value: $106.1K
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	230 Value: $9K
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	47 798 Value: $1.83M
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	4 599 Value: $179.4K
Nov 19, 2025 Sell	Class A Ordinary Shares S-Sale	Lloyd George W. EVP, Investments & Clo	Officer	2 470 Value: $96.3K
Nov 17, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	65 844 Value: $2.59M
Nov 17, 2025 Sell	Class A Ordinary Shares S-Sale	Coyne Terrance P. EVP & CFO	C-Suite Officer	3 750 Value: $147.4K
Nov 07, 2025 Buy	Class A Ordinary Shares C-Conversion	Urist Marshall EVP, Research & Investments	Officer	160 000 Value: $6.17M
Nov 07, 2025 Sell	LP interests in RPI US Partners 2019, LP C-Conversion	Urist Marshall EVP, Research & Investments	Officer	16 000 Value: $0
Nov 05, 2025 Buy	Class A Ordinary Shares A-Award	Urist Marshall EVP, Research & Investments	Officer	4 626 Value: $187.0K
Nov 05, 2025 Buy	Class A Ordinary Shares A-Award	Lloyd George W. EVP, Investments & Clo	Officer	6 168 Value: $249.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ROYALTY PHARMA PLC

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pha...

Read Full Profile Here